Skip to main content
SpringerLink
Log in

Mechanisms of inherited cancer susceptibility

  • Review
  • Published:
Journal of Zhejiang University SCIENCE B Aims and scope Submit manuscript

Abstract

A small proportion of many cancers are due to inherited mutations in genes, which result in a high risk to the individual of developing specific cancers. There are several classes of genes that may be involved: tumour suppressor genes, oncogenes, genes encoding proteins involved in DNA repair and cell cycle control, and genes involved in stimulating the angiogenic pathway. Alterations in susceptibility to cancer may also be due to variations in genes involved in carcinogen metabolism. This review discusses examples of some of these genes and the associated clinical conditions caused by the inheritance of mutations in such genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Antoniou, A., Pharoah, P.D.P., Narod, S., Risch, H.A., Eyfjord, J.E., Hopper, J.L., Loman, N., Olsson, H., Johannsson, O., Borg, A., et al., 2003. Average risks of breast and ovarian cancer associated with BRCA1 and BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet., 72(5):1117–1130. [doi:10.1086/375033]

    Article  PubMed  CAS  Google Scholar 

  • Bandipalliam, P., Garber, J., Kolodner, R.D., Syngal, S., 2004. Clinical presentation correlates with the type of mismatch repair gene involved in Hereditary Nonpolyposis Colon Cancer. Gastroenterology, 126(3):936–937. [doi:10.1053/j.gastro.2004.01.038]

    Article  PubMed  Google Scholar 

  • Eng, C., Mulligan, L.M., Healey, C.S., Houghton, C., Frilling, A., Raue, F., Thomas, G.A., Ponder, B.A.J., 1996. Heterogeneous mutation of the RET proto-oncogene in subpopulation of medullary thyroid carcinoma. Cancer Res., 56: 2167–2170.

    PubMed  CAS  Google Scholar 

  • Heiskanen, I., Luostarinen, T., Järvinen, H.J., 2000. Impact of screening examinations on survival in familial adenomatous polyposis. Scand. J. Gastroenterol., 35(12):1284–1287. [doi:10.1080/003655200453638]

    Article  PubMed  CAS  Google Scholar 

  • Hodgson, S.V., Foulkes, W., Eng, C., Maher, E.R., 2007. A Practical Guide to Inherited Cancer Susceptibility. Cambridge University Press, UK.

    Google Scholar 

  • Huang, H.Y., Yeo, J.K., Shaw, J.Y., Chen, P.L., Bookstein, R., Friedmann, T., Lee, E.Y., Lee, W.H., 1988. Suppression of neoplastic phenotype by replacement of the RB gene in human cancer cells. Science, 242(4885):1563–1566. [doi:10.1126/science.3201247]

    Article  PubMed  CAS  Google Scholar 

  • Ilyas, M., Tomlinson, I.P., 1997. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J. Pathol., 182(2):128–132. [doi:10.1002/(SICI)1096-9896(199706)182:2〈128::AID-PATH839〉3.0.CO;2-Q]

    Article  PubMed  CAS  Google Scholar 

  • Kennedy, R.K., Quinn, J.E., Johnston, P.G., Harkin, D., 2002. BRCA1: mechanisms of inactivation and implications for management of patients. Lancet, 360(9338):1007–1014. [doi:10.1016/S0140-6736(02)11087-7]

    Article  PubMed  CAS  Google Scholar 

  • Knudson, A.G., 1971. Mutation and human cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68(4):820–823. [doi:10.1073/pnas.68.4.820]

    Article  PubMed  Google Scholar 

  • Maher, E.R., Yates, J.R.W., Harries, R., Benjamin, C., Harris, R., Moore, A.T., Ferguson-Smith, M.A., 1990. Clinical features and natural history of von Hippel Lindau disease. Q. J. Med., 77(283):1151–1163.

    PubMed  CAS  Google Scholar 

  • Mangold, E., Pagenstecher, C., Leister, M., Mathiak, M., Rutten, A., Friedl, W., Propping, P., Ruzicka, T., Kruse, R., 2004. A genotype-phenotype correlation in HNPCC: strong predominance of MSH2 mutations in 41 patients with Muir-Torre syndrome. J. Med. Genet., 41(7):567–572. [doi:10.1136/jmg.2003.012997]

    Article  PubMed  CAS  Google Scholar 

  • Meijers-Heijboer, H., van Geel, B., van Putten, W.L., Henzen-Logmans, S.C., Seynaeve, C., Menke-Pluymers, M.B.E., Bartels, C.C.M., Verhoog, L.C., van den Ouweland, A.M.W., Niermeijer, M.F., et al., 2001. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med., 345(3):159–164. [doi:10.1056/NEJM200107193450301]

    Article  PubMed  CAS  Google Scholar 

  • Narod, S., 2001. Prophylactic mastectomy in carriers of BRCA mutations. N. Engl. J. Med., 345(20):1498. [doi:10.1056/NEJM200111153452014]

    Article  PubMed  CAS  Google Scholar 

  • Park, J.G., Kim, D.W., Hong, C.W., Nam, B.H., Shin, Y.K., Hong, S.H., Kim, I.J., Lim, S.B., Aronson, M., Bisgaard, M.L., et al., 2006. International Society for Gastrointestinal Hereditary Tumours. Germ line mutations of mismatch repair genes in Hereditary Nonpolyposis Colorectal Cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study. Clin. Cancer Res., 12(11 Pt 1):3389–3393. [doi:10.1158/1078-0432.CCR-05-2452]

    Article  PubMed  CAS  Google Scholar 

  • Peltomaki, P., Vasen, H., 2004. Mutations associated with HNPCC predisposition—update of ICG-HNPCC/INSiGHT mutation database. Dis. Markers, 20(4–5):269–276.

    PubMed  Google Scholar 

  • Rebbeck, T.R., Levin, A.M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber, J.E., Godwin, A.K., et al., 1999. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J. Natl. Cancer Inst., 91(17):1475–1479. [doi:10.1093/jnci/91.17.1475]

    Article  PubMed  CAS  Google Scholar 

  • Sampson, J.R., Dolwani, S., Jones, S., Eccles, D., Ellis, A., Evans, D., Frayling, I., Jordan, S., Maher, E., Mak, T., 2003. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet, 362(9377):39–41. [doi:10.1016/S0140-6736(03)13805-6]

    Article  PubMed  CAS  Google Scholar 

  • Sieber, O.M., Heinimann, K., Tomlinson, I.P., 2003. Genomic instability: the engine of tumourigenesis? Nat. Rev. Cancer, 3(9):701–708. [doi:10.1038/nrc1170]

    Article  PubMed  CAS  Google Scholar 

  • Thompson, D., Easton, D.F., 2002a. Breast cancer linkage consortium: variation in BRCA1 cancer risks by mutation position. Cancer Epidemiology, Biomarkers and Prevention, 11:326–329.

    Google Scholar 

  • Thompson, D., Easton, D.F., 2002b. Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers. J. Natl. Cancer Inst., 94(18):1358–1365.

    PubMed  CAS  Google Scholar 

  • Vasen, H.F., Stormorken, A., Menko, F.H., Nagengast, F.M., Kleibeuker, J.H., Griffioen, G., Taal, B.G., Moller, P., Wijnen, J.T., 2001. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of Hereditary Nonpolyposis Colorectal Cancer families. J. Clin. Oncol., 19(20):4074–4080.

    PubMed  CAS  Google Scholar 

  • Watson, P., Riley, B., 2005. The tumor spectrum in the Lynch syndrome. Fam. Cancer, 4(3):245–248. [doi:10.1007/s10689-004-7994-z]

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cancer Genetics, St Georges Hospital, University of London, London, SW17 ORE, UK

    Shirley Hodgson

Authors
  1. Shirley Hodgson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shirley Hodgson.

Additional information

Project supported by the Cancer Research, UK

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hodgson, S. Mechanisms of inherited cancer susceptibility. J. Zhejiang Univ. Sci. B 9, 1–4 (2008). https://doi.org/10.1631/jzus.B073001

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B073001

Key words

CLC number

Search

Navigation